Colts Neck, NJ – April 11, 2012 – United Health Products, Inc.(OTCQB:UEEC) which develops and markets products and technologies in the healthcare sector, today announced its affiliate, City 24/7 LLC, will start a pilot program next month with the City of New York. City 24/7 LLC will install 32-inch "smart screens" with broadband Internet connections in 250 old phone booths throughout the city. According to articles in the NY Times and NY Post, the hope is that eventually the City will replace its 12,800 outdoor pay phones with these new tablet-booths. The franchise for the public pay phones in New York City is expiring in October 2014.
The new touch-screen tablets will be free to access and will generate revenue via local advertising. People will be able to use the kiosks/tablets to get information on local restaurants, nearby stores, tourist attractions, and traffic updates. The booths will also provide access to NYC's 311 complaint and information line. And it will offer safety alerts. All of this will be available in multiple languages.
Eventually, users will also be able to access popular applications like Skype, which allows people to make phone calls over the Internet. And they'll be able to log on to e-mail accounts from the "smart screen" booths. The city also plans on turning the booths into Wi-Fi hot spots, which will provide wireless Internet access to other devices.
In an earlier pilot program, smart screens were installed during the past few years in places like Citi Field and the dormitories of New York University, according to Tom Touchet, the chief executive of City 24/7 LLC.
Dr. Phillip Forman, United's CEO, said, "While United is now focused on technologies for the healthcare sector, City 24/7 was one of the Company's earlier investments and the Company is proud that the City of New York has recognized the potential of the services and revenues streams to be derived from the installation of City 24/7's products in the City."
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and markets a patent pending hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp™, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on ramping up sales in its current markets as well as identifying new markets and applications for its products and technologies. For more information on United Health Products, Inc. please visit: www.unitedhealthproductsinc.com.
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements
United Health Products, Inc.
Dr. Phillip Forman, 732-239-3444